CLINICAL MANIFESTATIONS AND ANTIBODY PREVALENCE OF LYME BORRELIOSIS AND TICK-BORNE ENCEPHALITIS IN SWEDEN - A STUDY IN 5 ENDEMIC AREAS CLOSE TO STOCKHOLM
R. Gustafson et al., CLINICAL MANIFESTATIONS AND ANTIBODY PREVALENCE OF LYME BORRELIOSIS AND TICK-BORNE ENCEPHALITIS IN SWEDEN - A STUDY IN 5 ENDEMIC AREAS CLOSE TO STOCKHOLM, Scandinavian journal of infectious diseases, 25(5), 1993, pp. 595-603
Five populations, including 903 individuals living in 5 different area
s close to Stockholm, were studied with regard to clinical manifestati
ons and antibody prevalence of Lyme borreliosis (LB) and tick-borne en
cephalitis (TBE). The study areas involved 4 groups of islands in the
Baltic Sea and 1 island in Lake Malaren. Serum samples from each indiv
idual were tested for antibody activity to Borrelia burgdorferi using
a sonicated whole spirochete antigen in an ELISA, and to TBE-virus (TB
EV) by ELISA and haemagglutination inhibition. A history of LB was rep
orted by 1-21% and antibodies to Borrelia burgdorferi were found in 7-
29% of the participants from the various areas. An increasing seroprev
alence with age was seen. In sera from 3 different control groups, inc
luding 502 individuals living in non-endemic areas, antibodies to Borr
elia burgdorferi were detected in 1-2% and from 1 control group includ
ing 150 individuals living in the city of Stockholm, in 9%. A history
of TBE was reported by 0-6% of the individuals and in non-immunized in
dividuals seropositivity was seen in 4-22%, depending on the area inve
stigated. No antibody activity to TBEV could be detected in sera from
persons in the 3 control groups living in non-endemic areas, whereas 5
% of the controls from Stockholm were found to be positive. The preval
ence rates of antibodies to TBEV in persons vaccinated against TBE wer
e 40%, 53% and 79% after 1, 2 and 3 injections, respectively.